Results of two bi-institutional prospective studies using intraperitoneal oxaliplatin with or without irinotecan during HIPEC after cytoreductive surgery for colorectal carcinomatosis.

@article{Qunet2011ResultsOT,
  title={Results of two bi-institutional prospective studies using intraperitoneal oxaliplatin with or without irinotecan during HIPEC after cytoreductive surgery for colorectal carcinomatosis.},
  author={François Qu{\'e}net and Diane Go{\'e}r{\'e} and Sanket Sharad Mehta and Lise Roca and Fr{\'e}d{\'e}ric Dumont and Mehdi Hessissen and Bernard Saint-Aubert and Dominique Elias},
  journal={Annals of surgery},
  year={2011},
  volume={254 2},
  pages={294-301}
}
OBJECTIVE To assess the perioperative and long-term results of cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) using oxaliplatin+irinotecan (ox-irino) versus oxaliplatin alone (ox-alone). BACKGROUND Treatment of peritoneal carcinomatosis (PC) of colorectal origin with CRS+HIPEC using mitomycin-C or oxaliplatin monotherapy has shown encouraging survival results. This bi-centric study evaluates an intensified intraperitoneal combination of ox-irino and compares… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 47 extracted citations

Similar Papers

Loading similar papers…